To vent or not on veno-arterial extracorporeal membrane oxygenation, does it improve myocardial recovery and outcome?
Daniele Camboni, Christof Schmid
https://pubmed.ncbi.nlm.nih.gov/29312691Actively Recruiting
Led by Maastricht University Medical Center · Updated on 2025-01-09
500
Participants Needed
1
Research Sites
104 weeks
Total Duration
M
Maastricht University Medical Center
Lead Sponsor
I
IRCCS Policlinico S. Donato
Collaborating Sponsor
This international multicenter prospective observational study focuses on patients receiving veno-arterial extracorporeal life support (VA ECLS) for cardiogenic shock or cardiac arrest, conditions with very high hospital mortality rates. The research aims to understand left ventricular (LV) overload during VA ECLS and to describe and compare various LV unloading strategies in a large global patient group. The study also seeks to establish a shared definition of LV overload by collecting clinical, hemodynamic, and radiological data before and after unloading. Participants will undergo VA ECLS implantation as part of standard care for refractory cardiogenic shock or cardiac arrest. The study observes the use of different LV unloading techniques, collecting detailed information about when and how these strategies are applied. There are no additional interventions beyond the standard treatment necessary for patient care. During the study, researchers will gather demographic, clinical, instrumental, and laboratory data before and after VA ECLS implantation. They will monitor outcomes such as in-hospital mortality at 30 days and assess echocardiographic parameters related to LV overload and unloading effectiveness within 12 hours before and after the unloading technique. The study tracks patient progress to better understand the efficacy and impact of various LV unloading methods under real-world conditions.
CONDITIONS
ECMO LEft Ventricle UNloading Strategy
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Total: 1 location
1
Maastricht UMC
Maastricht, Netherlands
Actively Recruiting
P
Paolo Meani, MD, PhD
R
Roberto Lorusso, MD,PhD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Daniele Camboni, Christof Schmid
https://pubmed.ncbi.nlm.nih.gov/29312691Benedikt Schrage, Peter Moritz Becher, Alexander Bernhardt...
https://pubmed.ncbi.nlm.nih.gov/33032450Assad Haneya, Alois Philipp, Claudius Diez...
https://pubmed.ncbi.nlm.nih.gov/22819880Matthias Arlt, Alois Philipp, Sabine Voelkel...
https://pubmed.ncbi.nlm.nih.gov/22555310Dirk W Donker, Daniel Brodie, José P S Henriques...
https://pubmed.ncbi.nlm.nih.gov/30112975P Meani, R Lorusso, F Pappalardo
https://pubmed.ncbi.nlm.nih.gov/33642170Paolo Meani, Sandro Gelsomino, Eshan Natour...
https://pubmed.ncbi.nlm.nih.gov/28470925Paolo Meani, Thijs Delnoij, Giuseppe M Raffa...
https://pubmed.ncbi.nlm.nih.gov/30024298Sandeep M Patel, Jerry Lipinski, Sadeer G Al-Kindi...
https://pubmed.ncbi.nlm.nih.gov/29489461E Wilson Grandin, Jose I Nunez, Brooks Willar...
https://pubmed.ncbi.nlm.nih.gov/35361346